Google
NRXP — NRX PHARMACEUTICALS INC (Healthcare >> Biotechnology)
NRXP FAQ
What is NRXP's P/E ratio?
NRX PHARMACEUTICALS INC (NRXP) currently trades at a P/E ratio of 492.20.
What is NRXP's ROE?
NRX PHARMACEUTICALS INC reports a Return on Equity (ROE) of 177.63%.
What is NRXP's dividend yield?
NRX PHARMACEUTICALS INC offers a dividend yield of 0.00%.
What is NRXP's Deepscope Quality Score?
Deepscope rates NRXP's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy NRXP?
Deepscope's AI Timing Score for NRXP is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does NRXP belong to?
NRX PHARMACEUTICALS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 3.87
Price
-0.46
(-10.62%)
Day Change
|
|
|---|
NRXP, ファンダメンタルスコアはnot quite good ( ファンダメンタル = 54) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/Eが高い。割高銘柄。
ROAが低い
ROEの伸びが低い
ROAがROEに比べて低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 44 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 3.87 |
| PBV / Sector |
-12.83 / 4.71
|
| Earning Per Share | -0.54 |
| PE / Sector |
492.20 / 17.58
|
| PEG or PE/Growth / Sector |
3.11 / 0.53
|
| Average 1M Daily Value |
7.17 M
|
| Average 1W Daily Value |
10.20 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
52% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-10 09:43:46 |
| Symbol | NRXP |
| Name | NRX PHARMACEUTICALS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 42.80 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 177.19 / 8,889.42 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1201 N. Market Street, Wilmington, DE, United States, 19801
Phone: 484 254 6134
Website: https://www.nrxpharma.com
Sector: Healthcare >> Biotechnology
Description: NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone in Phase 2/3 clinical testing for bipolar depression with sub-acute ideation and behavior; NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression; and KETAFREE, a generic preservative-free formulation of ketamine. It also provides precision-based interventional psychiatry services to patients with treatment-resistant depression and PTSD using a combination of neuroplastic drugs, transcranial magnetic stimulation (TMS), digital therapeutics, and hyperbaric therapy; ketamine infusion therapy; stellate ganglion blocks; Spravato administration; psychotherapy; and medication management. The company has a development and license agreement with Glytech LLC. NRx Pharmaceuticals, Inc. was founded in 2015 and is headquartered in Wilmington, Delaware.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
